DK163799C - System bestaaende af to komponenter til afgivelse af topiske laegemidler samt pakning og dispenseringsanorning indeholende et saadant system - Google Patents

System bestaaende af to komponenter til afgivelse af topiske laegemidler samt pakning og dispenseringsanorning indeholende et saadant system

Info

Publication number: DK163799C
Authority: DK; Denmark
Prior art keywords: drug; phase; topical; medicinals; packaging
Prior art date: 1984-01-25

Application number

DK030585A

Other languages

English (en)

Other versions

DK30585A (da

DK30585D0 (da

DK163799B (da

Inventor

Adrian Francis Davis

Original Assignee

Beecham Group Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-01-25

Filing date

1985-01-23

Publication date

1992-08-31

1985-01-23 Application filed by Beecham Group Plc filed Critical Beecham Group Plc

1985-01-23 Publication of DK30585D0 publication Critical patent/DK30585D0/da

1985-07-26 Publication of DK30585A publication Critical patent/DK30585A/da

1992-04-06 Publication of DK163799B publication Critical patent/DK163799B/da

1992-08-31 Application granted granted Critical

1992-08-31 Publication of DK163799C publication Critical patent/DK163799C/da

Links

238000004806 packaging method and process Methods 0.000 title 1
230000000699 topical effect Effects 0.000 title 1
229940079593 drug Drugs 0.000 abstract 8
239000003814 drug Substances 0.000 abstract 8
239000012071 phase Substances 0.000 abstract 5
239000007788 liquid Substances 0.000 abstract 3
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 2
239000007791 liquid phase Substances 0.000 abstract 2
229920006395 saturated elastomer Polymers 0.000 abstract 2
239000000499 gel Substances 0.000 abstract 1
229960000890 hydrocortisone Drugs 0.000 abstract 1
238000011065 in-situ storage Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000035515 penetration Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000011369 resultant mixture Substances 0.000 abstract 1
238000011200 topical administration Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Confectionery (AREA)
Medicines Containing Plant Substances (AREA)

DK030585A 1984-01-25 1985-01-23 System bestaaende af to komponenter til afgivelse af topiske laegemidler samt pakning og dispenseringsanorning indeholende et saadant system DK163799C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB848401965A GB8401965D0 (en)	1984-01-25	1984-01-25	Composition
GB8401965		1984-01-25

Publications (4)

Publication Number	Publication Date
DK30585D0 DK30585D0 (da)	1985-01-23
DK30585A DK30585A (da)	1985-07-26
DK163799B DK163799B (da)	1992-04-06
DK163799C true DK163799C (da)	1992-08-31

Family

ID=10555518

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK030585A DK163799C (da)	1984-01-25	1985-01-23	System bestaaende af to komponenter til afgivelse af topiske laegemidler samt pakning og dispenseringsanorning indeholende et saadant system

Country Status (11)

Country	Link
US (1)	US4767751A (da)
EP (1)	EP0151953B1 (da)
JP (1)	JPS60174715A (da)
AT (1)	ATE71519T1 (da)
AU (1)	AU576344B2 (da)
CA (1)	CA1249520A (da)
DE (1)	DE3585162D1 (da)
DK (1)	DK163799C (da)
GB (1)	GB8401965D0 (da)
IE (1)	IE57733B1 (da)
ZA (1)	ZA85529B (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8629639D0 (en) *	1986-12-11	1987-01-21	Beecham Group Plc	Composition & method
US4940701A (en) *	1984-01-25	1990-07-10	Beecham Group P.L.C.	Topical drug release system
US4666441A (en) *	1985-12-17	1987-05-19	Ciba-Geigy Corporation	Multicompartmentalized transdermal patches
IE59628B1 (en) *	1986-06-26	1994-03-09	Beecham Group Plc	Treatment of fungal infections
EP0252459A1 (en) *	1986-07-07	1988-01-13	Schering Corporation	Compartmentalized transdermal delivery system
GB8629640D0 (en) *	1986-12-11	1987-01-21	Beecham Group Plc	Composition & method
IN168400B (da) *	1987-01-30	1991-03-23	Colgate Palmolive Co
US5180578A (en) *	1987-01-30	1993-01-19	Colgate-Palmolive Company	Antibacterial antiplaque anticalculus oral composition
US4894220A (en) *	1987-01-30	1990-01-16	Colgate-Palmolive Company	Antibacterial antiplaque oral composition
US5178851A (en) *	1987-01-30	1993-01-12	Colgate-Palmolive Company	Antiplaque antibacterial oral composition
US4935225A (en) *	1987-09-11	1990-06-19	Curtis John P	Appetite suppresant dentifrice
US5002938A (en) *	1988-03-21	1991-03-26	Bristol-Myers Squibb Company	Antifungal gel formulations
US5110809A (en) *	1988-03-21	1992-05-05	Bristol-Myers Squibb Company	Antifungal gel formulations
GB9021546D0 (en) *	1990-10-04	1990-11-21	Beecham Group Plc	Novel composition
US5681964A (en) *	1990-10-23	1997-10-28	University Of Kentucky Research Foundation	Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
GB9025711D0 (en) *	1990-11-27	1991-01-09	Beecham Group Plc	Topical composition
AU668679B2 (en) *	1991-02-18	1996-05-16	Transdermal Technologies Pty Limited	Composition for use in transdermal administration
GB9118711D0 (en) *	1991-08-31	1991-10-16	Smithkline Beecham Plc	Novel device
GB9125712D0 (en) *	1991-12-03	1992-01-29	Smithkline Beecham Plc	Skin care composition
GB9205194D0 (en) *	1992-03-10	1992-04-22	Smithkline Beecham Plc	Novel composition
GB9207988D0 (en) *	1992-04-10	1992-05-27	Smithkline Beecham Plc	Topical composition
US5314685A (en) *	1992-05-11	1994-05-24	Agouron Pharmaceuticals, Inc.	Anhydrous formulations for administering lipophilic agents
US5290541A (en) *	1992-06-18	1994-03-01	The Procter & Gamble Company	Methods for making oral compositions
FI944321A7 (fi) *	1992-11-05	1994-11-16	Becton Dickinson Co	Käyttäjäaktivoitu iontoforeettinen laite ja menetelmä sen käyttämiseks i
US5290542A (en) *	1993-04-08	1994-03-01	The Procter & Gamble Company	Oral compositions for treating plaque and gingivitis
US5474761A (en) *	1993-04-08	1995-12-12	The Procter & Gamble Company	Oral compositions for treating plaque and gingivitis
US5807569A (en) *	1993-05-27	1998-09-15	Smithkline Beecham P.L.C.	Topical composition
WO1995004520A1 (en) *	1993-08-06	1995-02-16	Embro William J	Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection
GB2306885B (en) *	1995-11-08	1999-07-14	Reckitt & Colmann Prod Ltd	Supersaturated Pharmaceutical Compositions
US5900249A (en) *	1998-02-09	1999-05-04	Smith; David J.	Multicomponent pain relief topical medication
US6765019B1 (en) *	1999-05-06	2004-07-20	University Of Kentucky Research Foundation	Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
KR100990810B1 (ko) *	2001-12-21	2010-10-29	알콘, 인코퍼레이티드	안과용 약물 및 이과용 약물을 위한 담체로서 합성 무기 나노입자의 용도
KR20040073503A (ko) *	2001-12-21	2004-08-19	알콘, 인코퍼레이티드	안과용 및 이과용 약제학적 조성물의 점도 및 기타물리학적 성질을 개질시키기 위한 무기 나노입자의 용도
IL150907A (en) *	2002-07-25	2007-07-04	Stephan Cherkez	Process for the preparation of stable amorphous calcium pseudomonate
US20090017047A1 (en) *	2004-06-11	2009-01-15	Egon Tech	Preparation for the Prevention and Treatment of Stress Conditions as Well as Functional and Organic Disorders of the Nervous System and Metabolic Disorders
EP2457560A1 (en)	2006-06-14	2012-05-30	Dr Reddy's Laboratories Limited	Topical compositions
US20080317684A1 (en) *	2006-09-06	2008-12-25	Isw Group, Inc.	Topical Compositions
US8114159B2 (en)	2006-11-20	2012-02-14	Depuy Spine, Inc.	Anterior spinal vessel protector
PE20130245A1 (es) *	2009-12-16	2013-03-08	Shasun Pharmaceuticals Ltd	Composicion de hidrogel de dexibuprofeno transdermico
US8809307B2 (en)	2010-11-22	2014-08-19	Dow Pharmaceutical Sciences, Inc.	Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en)	2010-11-22	2024-04-16	Bausch Health Ireland Limited	Pharmaceutical formulations containing corticosteroids for topical administration
PT2704703T (pt)	2011-05-03	2019-10-25	Aponia Laboratories Inc	Composições transdermais de ibuprofeno e seus métodos de utilização.
KR102643849B1 (ko)	2015-06-18	2024-03-07	밸리언트 파마슈티컬즈 노오쓰 아메리카 엘엘씨	건선을 치료하기 위한 코르티코스테로이드 및 레티노이드를 포함하는 국소 조성물
US11311482B2 (en)	2017-05-12	2022-04-26	Bausch Health Us, Llc	Topical compositions and methods for treating skin diseases
CA3117842A1 (en)	2018-10-26	2020-04-30	Viramal Limited	Mucoadhesive gel composition
ES2948955T3 (es)	2018-11-30	2023-09-22	Viramal Ltd	Un método de preparación de un agente gelificante, el agente gelificante obtenido de este modo y el uso de dicho agente gelificante
JP2024540701A (ja)	2021-11-08	2024-11-01	リー・ウェイヨン	患者に薬物を送達するための経皮薬物送達システム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1582207A (en) *	1977-05-16	1981-01-07	Sanol Arznei Schwarz Gmbh	Stable isosorbide dinitrate solutions preparation thereof and use thereof
US4140656A (en) *	1977-10-07	1979-02-20	Armour-Dial, Inc.	Anhydrous clear gel facial cleanser
JPS5850964B2 (ja) *	1978-03-07	1983-11-14	東興薬品工業株式会社	ステロイド含有クリ−ム製剤およびその製造方法
US4602040A (en) *	1983-04-18	1986-07-22	Warner-Lambert Company	Meclofenamic acid topical pharmaceutical composition

1984
- 1984-01-25 GB GB848401965A patent/GB8401965D0/en active Pending
1985
- 1985-01-17 AT AT85100447T patent/ATE71519T1/de not_active IP Right Cessation
- 1985-01-17 EP EP85100447A patent/EP0151953B1/en not_active Expired - Lifetime
- 1985-01-17 DE DE8585100447T patent/DE3585162D1/de not_active Expired - Fee Related
- 1985-01-23 CA CA000472658A patent/CA1249520A/en not_active Expired
- 1985-01-23 DK DK030585A patent/DK163799C/da not_active IP Right Cessation
- 1985-01-23 IE IE146/85A patent/IE57733B1/en not_active IP Right Cessation
- 1985-01-23 ZA ZA85529A patent/ZA85529B/xx unknown
- 1985-01-23 AU AU38008/85A patent/AU576344B2/en not_active Ceased
- 1985-01-23 US US06/693,770 patent/US4767751A/en not_active Expired - Lifetime
- 1985-01-25 JP JP60012342A patent/JPS60174715A/ja active Granted

Also Published As

Publication number	Publication date
EP0151953A2 (en)	1985-08-21
AU3800885A (en)	1985-08-01
AU576344B2 (en)	1988-08-25
JPS60174715A (ja)	1985-09-09
CA1249520A (en)	1989-01-31
ATE71519T1 (de)	1992-02-15
IE850146L (en)	1985-07-25
EP0151953A3 (en)	1987-01-21
JPH0430923B2 (da)	1992-05-25
EP0151953B1 (en)	1992-01-15
DK30585A (da)	1985-07-26
DK30585D0 (da)	1985-01-23
DE3585162D1 (de)	1992-02-27
IE57733B1 (en)	1993-04-07
GB8401965D0 (en)	1984-02-29
DK163799B (da)	1992-04-06
ZA85529B (en)	1985-11-27
US4767751A (en)	1988-08-30

Legal Events

Date	Code	Title	Description
2003-09-01	PBP	Patent lapsed	Country of ref document: DK

Publication	Publication Date	Title
DK163799C (da)	1992-08-31	System bestaaende af to komponenter til afgivelse af topiske laegemidler samt pakning og dispenseringsanorning indeholende et saadant system
KR870005652A (ko)	1987-07-06	다구획화된 피부 및 경피용 패치
SE8402389D0 (sv)	1984-05-03	Komposition for transdermalt terapeutiskt system
DE3787624D1 (de)	1993-11-04	Oertliches arzneimittel mit verzoegerter wirkstoffabgabe.
NO881910D0 (no)	1988-04-29	Fremgangsmaate til behandling av abstinenssymptomer hos personer som slutter aa roeke og preparater til bruk i fremgangsmaaten.
KR900701274A (ko)	1990-12-01	남용 가능성을 감소시킨 용량 제형
AU583934B2 (en)	1989-05-11	Device for connecting one end of a liquid medicament delivery cannula to an apparatus for connecting a syringe to a vial containing the medicament
DK161988C (da)	1992-02-10	Vaeskeafgivende pumpeindretning til afgivelse af forudbestemte maengder
MY101570A (en)	1991-12-17	Novel pharmaceutical compositions for topical application with systemic action
GR3018967T3 (en)	1996-05-31	Supersaturated topical compositions.
DK649487A (da)	1988-06-12	Praeparat til afgivelse af et topisk laegemiddel
NO790917L (no)	1979-09-21	N-oksacyklyl-alkyl-piperidin, fremgangsmaate til deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelser, samt deres terapeutiske anvendelse
DE69426844D1 (de)	2001-04-19	Halbfeste Arzneimittel sowie Verfahren zu deren Herstellung
FI843609A7 (fi)	1985-03-17	Nestemäiset, ionisia aineosia sisältävät farmaseuttiset valmisteet, jotka pidentävät lääkeaineen vapautumista.
KR910021238A (ko)	1991-12-20	켈로이드 치료제
DK2488D0 (da)	1988-01-05	Dopamin-beta-hydroxylaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
BE811027A (fr)	1974-05-29	Dispositif de melange homogene et de separation de deux phases liquides ou plus
ATE156714T1 (de)	1997-08-15	System zur transdermalen zuführung von arzneien
KR970705921A (ko)	1997-11-03	활성물질을 식물에 투여하기 위한 압력작동형 무침 주사장치의 용도
IT8019572A0 (it)	1980-01-30	Dispositivo di iniezione senza agodi sostanze medicamentose liquide.
JPS51123834A (en)	1976-10-28	A medicine against the headache
ITMI922312A1 (it)	1994-04-07	Dispositivo perfezionato per il dosaggio di sostanze liquide in genere, in operazioni di imbottigliamento
GB1446614A (en)	1976-08-18	Phamaceutical compositions containing anti-allergy drugs
FR1364401A (fr)	1964-06-19	Dispositif de dosage continu des constituants liquides et gazeux contenus dans des mélanges
DK39891A (da)	1991-03-06	N-(2-aminoethyl)-pyridin-2-carboxamid og farmaceutisk anvendelige syreadditionssalte deraf til anvendelse som terapeutisk virksomme stoffer samt laegemidler indeholdende disse forbindelser